In the rd10 model of RP, stabilization of HIF-1α via prolyl hydroxylase inhibition with the 2-oxoglutarate analog DMOG recovers at least in part the retinal levels of HIF-1/VEGF [5]. The gene discussed is HIF1A; the disease is retinitis pigmentosa 1.